IMP GMP MANUFACTURING?

NEW GMP MANUFACTURER
OF CLINICAL TRIAL MATERIAL

IMP GMP MANUFACTURE

THE CRO / CDMO SPECIALISTS

IN TOPICAL PHARMACEUTICALS

About

DON'T GET STUCK
IN THE MIDDLE

GET END-TO-END DEVELOPMENT

Why Zelmic

THE ONLY IVRT / IVPT

SERVICE IN THE NORDIC REGION

Performance testing

DEMONSTRATED
BIOEQUIVALENCE

FOR YOUR TOPICAL PRODUCT

Topical generics

About

YOUR CRO / CDMO PARTNER

Zelmic is a proven and reliable CRO / CDMO partner combining regulatory and scientific knowledge in a fast, flexible and quality-focused organization. Our experts in semisolids are focused entirely on topical formulations and drug delivery and can lead you through the entire development process. We are located in Lund, Sweden, one of the top science hubs in Europe conveniently connected with Copenhagen and Stockholm, and home to numerous life science companies.

About Us

FULL SPECTRUM OF SERVICES

Turn your ideas into effective topical drug products by taking advantage of our fast, cost-efficient, risk mitigating and GMP approved services. These range from formulation development, stability testing, analytical method development and validation, to In-Vitro Release Testing (IVRT), In-Vitro Skin Permeation Testing (IVPT) and IMP GMP Manufacturing.

PRODUCT
DEVELOPMENT

IMP GMP
Manufacture

ANALYTICAL
CHEMISTRY

PERFORMANCE
TESTING

Latest news & events

Summer reflections, updates and new milestones at Zelmic

As we head into the summer months, we want to take a moment to share some exciting updates from our team at Zelmic. New license We’ve reached two important milestones. We’ve obtained our MIA license, where we can help clients with imports from third countries, allowing us to manage global supply chains more efficiently and…

Bridging the Gap: The Importance of IVIVC in Topical Drug Development

In the development of topical drug formulations, one of the greatest challenges is ensuring that in vitro (laboratory-based) tests accurately reflect how a drug will behave in vivo (on human skin). This is where In Vitro-In Vivo Correlation (IVIVC) plays a crucial role. A strong IVIVC allows pharmaceutical developers to predict drug absorption, efficacy, and…

New chapter: Zelmic Becomes Part of CTR Group through acquisition

Center for Translational Research AB (CTR) expands by acquiring Zelmic AB, the GMP-approved Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), specialized in development of topical and transdermal pharmaceutical formulations and drug delivery. The acquisition further expands CTRs portfolio, within pharmaceutical, regulatory, and clinical development to the CTR group.

See all news